Baclofen is a skeletal muscle relaxant. Baclofen Sintetica® for intrathecal use is indicated in patients with severe chronic spasticity originating from trauma, multiple sclerosis or other spinal cord disorders.
BEMFOLA®, a recombinant-human Follicle Stimulating Hormone (r hFSH) commercialised by Gedeon Richter, is a biosimilar to GONAL-f®, an established reference product. BEMFOLA® is produced using recombinant DNA technology.
CardioCel® developed by Admedus, is a CE-marked implantable cardiovascular bio-scaffold that can be used to repair congenital heart deformities and more complex heart defects including heart valves, in both pediatric and adult patients.
Exondys 51 (eteplirsen) is an injectable solution developed by Sarepta Therapeutics, indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping.
uropharmagen® is a genetic test, developed by AB Biotics, Spain, for use in neurology and psychiatry that identifies the safest and most appropriate medication for each individual patient by analyzing their DNA.
Noradrenalin Sintetica® is a medicine that belongs to the group of adrenergic and dopaminergic agents. It is indicated for the emergency restoration of blood pressure in cases of suddenly decreased blood pressure (acute hypotension).
Translarna™, developed by PTC Therapeutics, is indicated for the treatment of Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 5 years and older.